Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 4.2.1.75 - uroporphyrinogen-III synthase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abortion, Spontaneous
Dibromochloropropane: epidemiological findings and current questions.
Anemia
Levels of delta-aminolevulinate dehydratase, uroporphyrinogen-I synthase, and protoporphyrin IX in erythrocytes from anemic mutant mice.
Anemia, Hemolytic
Erythrodontia in congenital erythropoietic porphyria.
Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.
Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
Carcinogenesis
Dibromochloropropane: epidemiological findings and current questions.
Carcinoma
Mouse mammary carcinoma porphobilinogenase and hydroxymethylbilane synthetase.
Coproporphyria, Hereditary
Congenital erythropoietic porphyria: clinical, biochemical, and enzymatic profile of a severely affected infant.
coproporphyrinogen oxidase deficiency
Congenital erythropoietic porphyria: clinical, biochemical, and enzymatic profile of a severely affected infant.
Erectile Dysfunction
Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
Genetic Diseases, Inborn
Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models.
Advances in understanding the pathogenesis of congenital erythropoietic porphyria.
Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.
Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal.
Glioma
Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas.
TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.
Hematologic Neoplasms
Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations. A case report.
Infertility
Dibromochloropropane: epidemiological findings and current questions.
Intraabdominal Infections
The uroS and yifB Genes Conserved among Tetrapyrrole Synthesizing-Deficient Bacteroidales Are Involved in Bacteroides fragilis Heme Assimilation and Survival in Experimental Intra-abdominal Infection and Intestinal Colonization.
Leukemia, Erythroblastic, Acute
Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
Myelodysplastic Syndromes
Late-onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation.
Neoplasms
Heme biosynthesis in human breast cancer--mimetic "in vitro" studies and some heme enzymic activity levels.
Mouse mammary carcinoma porphobilinogenase and hydroxymethylbilane synthetase.
TCGA mRNA Expression Analysis of the Heme Biosynthesis Pathway in Diffusely Infiltrating Gliomas: A Comparison of Typically 5-ALA Fluorescent and Non-Fluorescent Gliomas.
The gut microbiota metabolite urolithin A, but not other relevant urolithins, induces p53-dependent cellular senescence in human colon cancer cells.
Photosensitivity Disorders
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria.
Porphyria, Acute Intermittent
A simple method for measuring erythrocyte porphobilinogenase, and its use in the diagnosis of acute intermittent porphyria.
Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.
Porphyria, Erythropoietic
A Case of Congenital Erythropoietic Porphyria without Hemolysis.
A knock-in mouse model of congenital erythropoietic porphyria.
A molecular study of congenital erythropoietic porphyria in cattle.
A systematic analysis of the mutations of the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models.
Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations. A case report.
Advances in understanding the pathogenesis of congenital erythropoietic porphyria.
ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
Bone Marrow Transplantation in Congenital Erythropoietic Porphyria: Sustained Efficacy but Unexpected Liver Dysfunction.
Bone-marrow transplantation for congenital erythropoietic porphyria.
Bullous skin lesions in a jaundiced infant after phototherapy: a case of congenital erythropoietic porphyria.
C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
Coexistence of deficiencies of uroporphyrinogen III synthase and decarboxylase in a patient with congenital erythropoietic porphyria and in his family.
Compound heterozygosity for a premature termination codon and missense mutation in the exon 10 of the uroporphyrinogen III cosynthase gene causes a severe phenotype of congenital erythropoietic porphyria.
Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Congenital erythropoietic porphyria associated with myelodysplasia presenting in a 72-year-old man: report of a case and review of the literature.
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria.
Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation.
Congenital erythropoietic porphyria with two mutations of the uroporphyrinogen III synthase gene (Cys73Arg, Thr228Met).
Congenital Erythropoietic Porphyria with Undescended Testis.
Congenital erythropoietic porphyria.
Congenital erythropoietic porphyria. A mild variant with low uroporphyrin I levels due to a missense mutation (A66V) encoding residual uroporphyrinogen III synthase activity.
Congenital erythropoietic porphyria: a case report.
Congenital erythropoietic porphyria: A case series of a rare uroporphyrinogen III synthase gene mutation in Nepalese patients.
Congenital erythropoietic porphyria: a case where symptoms have been precipitated by an unrelated anaemia.
Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts.
Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases.
Congenital Erythropoietic Porphyria: Characterization of Murine Models of the Severe Common (C73R/C73R) and Later-Onset Genotypes.
Congenital erythropoietic porphyria: clinical, biochemical, and enzymatic profile of a severely affected infant.
Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene.
Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene.
Congenital erythropoietic porphyria: identification and expression of exonic mutations in the uroporphyrinogen III synthase gene.
Congenital erythropoietic porphyria: mild presentation with late onset associated with a mutation in the UROS gene promoter sequence.
Congenital Erythropoietic Porphyria: Mutation of the Uroporphyrinogen III Cosynthase Gene in a Vietnamese Patient.
Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.
Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
Coupled-enzyme and direct assays for uroporphyrinogen III synthase activity in human erythrocytes and cultured lymphoblasts. Enzymatic diagnosis of heterozygotes and homozygotes with congenital erythropoietic porphyria.
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.
Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.
Fluorescence-based selection of retrovirally transduced cells in congenital erythropoietic porphyria: direct selection based on the expression of the therapeutic gene.
Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.
Heterogeneity of mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
Human uroporphyrinogen III synthase: molecular cloning, nucleotide sequence, and expression of a full-length cDNA.
Human uroporphyrinogen III synthase: NMR-based mapping of the active site.
Identification of a novel UROS mutation in a Chinese patient affected by congenital erythropoietic porphyria.
Identification of mutations in the uroporphyrinogen III cosynthase gene in German patients with congenital erythropoietic porphyria.
Identification of mutations in the uroporphyrinogen III synthase gene in a Thai girl patient with congenital erythropoietic porphyria.
Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy.
Identification of two new mutations in congenital erythropoietic porphyria.
Immunological, enzymatic and biochemical studies of uroporphyrinogen III-synthase deficiency in 20 patients with congenital erythropoietic porphyria.
Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria.
Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria.
Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease).
Intracellular Rescue of the Uroporphyrinogen III Synthase Activity in Enzymes Carrying the Hotspot Mutation C73R.
Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.
Late-onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation.
Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells.
Lentivirus-mediated gene transfer of uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells.
Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein-Barr virus-transformed B-cell lines.
Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.
Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
Molecular basis of congenital erythropoietic porphyria: mutations in the human uroporphyrinogen III synthase gene.
Molecular genetics of congenital erythropoietic porphyria.
Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells.
Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria.
Novel point mutation in the uroporphyrinogen III synthase gene causes congenital erythropoietic porphyria of a Japanese family.
Point mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria (Günther's disease).
Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal.
Prenatal diagnosis in congenital erythropoietic porphyria by metabolic measurement and DNA mutation analysis.
Report of a novel Indian case of congenital erythropoietic porphyria and overview of therapeutic options.
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.
Structural, thermodynamic, and mechanistical studies in uroporphyrinogen III synthase:Molecular basis of congenital erythropoietic porphyria.
Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria.
Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease).
Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease).
Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.
Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature.
Tuning intracellular homeostasis of human uroporphyrinogen III synthase by enzyme engineering at a single hotspot of congenital erythropoietic porphyria.
Two brothers with mild congenital erythropoietic porphyria due to a novel genotype.
Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria.
Uroporphyrinogen III Synthase Knock-In Mice Have the Human Congenital Erythropoietic Porphyria Phenotype, Including the Characteristic Light-Induced Cutaneous Lesions.
Uroporphyrinogen III synthase mutations related to congenital erythropoietic porphyria identify a key helix for protein stability.
Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene.
[Congenital erythropoeietic porphyria treated by haematopoietic stem cell allograft].
[Congenital erythropoietic porphyria. Apropos of a fatal case in the neonatal period due to acute hemolysis with hepatic failure]
[Congenital erythropoietic porphyria: case report and management recommendations].
[Successful gene therapy of mice with congenital erythropoietic porphyria]
Porphyrias
A simple method for measuring erythrocyte porphobilinogenase, and its use in the diagnosis of acute intermittent porphyria.
Congenital Erythropoietic Porphyria with Erythrodontia: A Case Report.
Congenital erythropoietic porphyria: a case where symptoms have been precipitated by an unrelated anaemia.
Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases.
Coupled-enzyme and direct assays for uroporphyrinogen III synthase activity in human erythrocytes and cultured lymphoblasts. Enzymatic diagnosis of heterozygotes and homozygotes with congenital erythropoietic porphyria.
Crystal structure of human uroporphyrinogen III synthase.
Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.
Late-onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation.
Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells.
Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria.
[Congenital erythropoietic porphyria: case report and management recommendations].
Prostatic Hyperplasia
Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
Protoporphyria, Erythropoietic
Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells.
protoporphyrin ferrochelatase deficiency
Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.
Urologic Diseases
Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
uroporphyrinogen-iii synthase deficiency
A knock-in mouse model of congenital erythropoietic porphyria.
Bone-marrow transplantation for congenital erythropoietic porphyria.
Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.
Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
[Congenital erythropoietic porphyria: case report and management recommendations].